glp-1 how it works The revolution: What UAB researchers are discovering about these drugs work Glucagon-like peptide 1 (GLP-1) -
Description
The basal forebrain cholinergic system in aging and dementia

With rapid adoption rates, ongoing innovations (including oral GLP-1 options now entering the market), and sustained consumer interest, the impact on medical aesthetics will continue through 2026 and beyond

The research team compared the outcomes of patients on GLP-1 drugs against those taking another type of diabetes drug called sodium-glucose cotransporter-2 inhibitors, or SGLT2Is
The choice of GLP-1s can be influenced by co-morbidities

FDA Investigating Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas From Incretin Mimetic Drugs for Type 2 Diabetes
